Suchergebnisse - "Davis, Hugh"

PubPharm (28)

1

Development of a Target cell-Biologics-Effector cell (TBE) complex-based cell killing model to characterize target cell depletion by T cell redirecting bispecific agents

enthalten in: mAbs | 2018

von Jiang, X. | Chen, X. | Carpenter, T. | +5

2

Pharmacokinetics and Exposure Response Relationships of Ustekinumab in Patients With Crohn's Disease

enthalten in: Gastroenterology | 2018

von Adedokun, O. | Xu, Z. | Gasink, C. | +9

3

Non-Clinical Pharmacokinetics, Prediction of Human Pharmacokinetics and First-in-Human Dose Selection for CNTO 5825, an Anti-Interleukin-13 Monoclonal Antibody

enthalten in: Basic & clinical pharmacology & toxicology | 2015

von Nnane, I. | Xu, Z. | Zhou, H. | +1

4

Dose selection of siltuximab for multicentric Castleman's disease

enthalten in: Cancer chemotherapy and pharmacology | 2015

von Mayer, C. | Xie, L. | Bandekar, R. | +6

5

Pharmacokinetic bridging approach for developing biologics-delivery devices : a case study with a golimumab autoinjector

enthalten in: Clinical therapeutics | 2015

von Xu, Z. | Marciniak, S. | Frederick, B. | +4

6

Association between serum concentration of infliximab and efficacy in adult patients with ulcerative colitis

enthalten in: Gastroenterology | 2014

von Adedokun, O. | Sandborn, W. | Feagan, B. | +8

7

A phase 1, randomized study to assess the pharmacokinetic comparability of siltuximab derived from two different cell lines in healthy subjects

enthalten in: Clinical pharmacology in drug development | 2014

von Xu, C. | Han, C. | Marini, J. | +9

8

Pharmacokinetics of infliximab in children with moderate-to-severe ulcerative colitis : results from a randomized, multicenter, open-label, phase 3 study

enthalten in: Inflammatory bowel diseases | 2013

von Adedokun, O. | Xu, Z. | Padgett, L. | +8

9

Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human study

enthalten in: British journal of clinical pharmacology | 2013

von van Hartingsveldt, B. | Nnane, I. | Bouman-Thio, E. | +4

10

Comparison of the pharmacokinetics of subcutaneous ustekinumab between Chinese and non-Chinese healthy male subjects across two Phase 1 studies

enthalten in: Clinical drug investigation | 2013

von Zhu, Y. | Wang, Q. | Frederick, B. | +6